Proton pump inhibitors and the risk of cardiovascular events and cardiovascular mortality: A systematic review and meta-analysis of observational studies

CONCLUSION: It is questionable, whether PPI monotherapy constitutes a cardiovascular risk factor.PMID:36195531 | DOI:10.1016/j.ejim.2022.09.021

Source: European Journal of Internal Medicine - October 4, 2022 Category: Internal Medicine Authors: Michael Nolde Nayeon Ahn Tobias Dreischulte Evamaria Krause Florian G üntner Alexander G ünter Roman Gerlach Martin Tauscher Ute Amann Jakob Linseisen Christa Meisinger Sebastian-Edgar Baumeister Ina-Maria R ückert-Eheberg Source Type: research